Must-watch: Vineti’s Women in Tech panel discussion
ers across healthcare and technology! The event was moderated by Kat Noren, SVP of People and Places at Vineti, with panelists including Heidi Rozen, Partner…
Autolomous and Vineti form strategic partnership to deliver end to end supply chain management solutions for cell and gene therapy sector
Autolomous LTD, the market leading developer of critical manufacturing management systems for cell and gene therapies, and Vineti, a provider of leading digital enterprise platforms…
Körber and Vineti Announce Partnership to Provide Improved Manufacturing Performance and Visibility Globally for Cell and Gene-Based Therapies
Körber, the leading MES supplier for pharma and biotech, and Vineti, the world’s only enterprise software platform supporting supply chain orchestration for clinical and commercial…
Lykan Bioscience and Vineti Announce Partnership to Advance Cell-based Therapies from Clinical to Commercialization
Lykan Bioscience’s world-class manufacturing capabilities, integrated with Vineti’s leading digital enterprise platform for cell and gene therapy supply chains, will streamline process development and manufacturing…
Vineti announces agreement with Imvax to utilize Vineti’s PTM Essentials™ solution
Vineti’s enterprise technology will enable critical patient-specific Chain of Custody management for Imvax, supporting Imvax’s goal of reaching more patients as fast as possible
Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require
Introducing new Vineti PTM® flexibility features: next-gen label printing and rescheduling innovations deliver critical workflow options that advanced therapies require...
The Vineti Alliance Network — a preview of what’s next
For Vineti, 2020 has been all about continuing to deliver progress for advanced therapies, even amid an unpredictable year. One...
Vineti Extends Series C Funding Round to $68M with an Expanded Investor Coalition
Today, we’re very excited and honored to announce the extension of our Series C round of funding. We’ve expanded the...
Vineti at Cell and Gene Meeting on the Mesa 2020
Next week marks the start of a very important annual event in advanced therapies — the Alliance for Regenerative Medicine’s...
Crispr’s Nobel Moment
“Crispr — overrated or underrated?” At this month’s CBInsights Future of Health conference, I had the good fortune to do a live...
Vineti Announces New Chief Commercial Officer
Proven biotech/pharma executive and advanced therapies pioneer Joe DePinto brings extensive commercial expertise to the industrialization of cell and gene...
Q&A: five questions for Joe DePinto
Today, Vineti is thrilled to announce that Joe DePinto has joined us as our Chief Commercial Officer. Joe is a long-time leader in...